Literature DB >> 15800915

Melatonin potentiates flavone-induced apoptosis in human colon cancer cells by increasing the level of glycolytic end products.

Uwe Wenzel1, Alexander Nickel, Hannelore Daniel.   

Abstract

Melatonin is a natural compound synthesized by a variety of organs. It has been described to possess cell protecting activity in normal cells but was shown to induce apoptotic cell death in cancer cells. We determined to which extent and based on which molecular mechanisms melatonin is able to cause apoptosis in HT-29 human colon cancer cells. Induction of apoptosis was assessed by caspase-3-like activity, nuclear fragmentation and chromatin condensation. Melatonin, when given alone at a concentration of 1 mM, did not affect any of the apoptosis markers. It potentiated apoptosis induced by the flavonoid flavone significantly. Whereas flavone alone at a concentration of 150 microM led to a 8-fold increase in caspase-3-like activity associated with around 40% of cells displaying DNA-fragmentation, a combination of flavone and melatonin increased caspase-3-like activity 30-fold and 80% of cells exhibited fragmentation of DNA when compared to untreated controls. Melatonin caused an increase in cytosolic lactate levels that most likely allows the flavone-induced activation of the mitochondrial pyruvate/lactate importer to deliver more substrates to mitochondrial respiration. The subsequent increased production of mitochondrial O2-* in the presence of flavone was further increased by melatonin. Scavenging mitochondrial O2-* by benzoquinone or blocking the lactate/pyruvate transporter by 5-nitro-2-(3-phenylpropylamino) benzoate inhibited mitochondrial O2-* -generation and apoptosis execution mediated by flavone and melatonin. Our study provides evidence that melatonin potentiates flavone-induced apoptosis in HT-29 human colon cancer cells by enhancing the level of oxidizable substrates that can be transported into mitochondria in the presence of flavone. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15800915     DOI: 10.1002/ijc.20837

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

Review 1.  Melatonin transport into mitochondria.

Authors:  Juan C Mayo; Rosa M Sainz; Pedro González-Menéndez; David Hevia; Rafael Cernuda-Cernuda
Journal:  Cell Mol Life Sci       Date:  2017-08-21       Impact factor: 9.261

2.  Therapeutic actions of melatonin on gastrointestinal cancer development and progression.

Authors:  Rachael Glenister; Kelly McDaniel; Heather Francis; Julie Venter; Kendal Jensen; Giuseppina Dusio; Eugenio Gaudio; Shannon Glaser; Fanyin Meng; Gianfranco Alpini
Journal:  Transl Gastrointest Cancer       Date:  2013-01-01

Review 3.  Distribution, function and physiological role of melatonin in the lower gut.

Authors:  Chun-Qiu Chen; Jakub Fichna; Mohammad Bashashati; Yong-Yu Li; Martin Storr
Journal:  World J Gastroenterol       Date:  2011-09-14       Impact factor: 5.742

4.  Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells.

Authors:  Ignacio Bejarano; Javier Espino; Ana M Marchena; Carmen Barriga; Sergio D Paredes; Ana B Rodríguez; José A Pariente
Journal:  Mol Cell Biochem       Date:  2011-03-23       Impact factor: 3.396

5.  Different Effects of Melatonin on X-Rays-Irradiated Cancer Cells in a Dose-Dependent Manner.

Authors:  Hao Zhu; Yong Chen; Liang-Cai Bai; Xiang-Rong Cao; Rui Xu
Journal:  Dose Response       Date:  2019-09-23       Impact factor: 2.658

Review 6.  An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.

Authors:  Saeed Mehrzadi; Mohammad Hossein Pourhanifeh; Alireza Mirzaei; Farid Moradian; Azam Hosseinzadeh
Journal:  Cancer Cell Int       Date:  2021-03-31       Impact factor: 5.722

Review 7.  Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells.

Authors:  Carmen Rodriguez; Vanesa Martín; Federico Herrera; Guillermo García-Santos; Jezabel Rodriguez-Blanco; Sara Casado-Zapico; Ana María Sánchez-Sánchez; Santos Suárez; Noelia Puente-Moncada; María José Anítua; Isaac Antolín
Journal:  Int J Mol Sci       Date:  2013-03-25       Impact factor: 5.923

8.  Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.

Authors:  Jian-Jun Lu; Lingyi Fu; Zhipeng Tang; Changlin Zhang; Lijun Qin; Jingshu Wang; Zhenlong Yu; Dingbo Shi; Xiangsheng Xiao; Fangyun Xie; Wenlin Huang; Wuguo Deng
Journal:  Oncotarget       Date:  2016-01-19

Review 9.  The role of melatonin in colorectal cancer treatment: a comprehensive review.

Authors:  Mindaugas Kvietkauskas; Viktorija Zitkute; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Ther Adv Med Oncol       Date:  2020-07-17       Impact factor: 8.168

10.  NEDD9 Inhibition by miR-25-5p Activation Is Critically Involved in Co-Treatment of Melatonin- and Pterostilbene-Induced Apoptosis in Colorectal Cancer Cells.

Authors:  Ji Hoon Jung; Eun Ah Shin; Ju-Ha Kim; Deok Yong Sim; Hyemin Lee; Ji Eon Park; Hyo-Jung Lee; Sung-Hoon Kim
Journal:  Cancers (Basel)       Date:  2019-10-29       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.